BPC-157
Purity: 99.49%
Batch #: BPC-157-10-601
Verified Potency: 12.78mg
$99.00
BPC-157 is a synthetic peptide fragment used in research involving gastrointestinal, angiogenic, and inflammatory pathways.
Ships by
Calculating...
Disclaimer
For Research Use Only. Not for human consumption or therapeutic treatment.
About BPC-157
BPC-157 is a 15-amino-acid peptide derived from a protective protein found in gastric juice. Research frequently explores its role in angiogenesis, cellular repair, nitric-oxide modulation, and tissue homeostasis models. Its stability in various environments makes it useful for studying systemic and gut-related pathways. BPC-157 remains one of the most widely used compounds in regeneration and inflammatory response research.
Product Specifications
BPC-157 Lyophilized Powder in 3ml vial
Application
Gastrointestinal, inflammatory, and angiogenesis research
Appearance
Solid, white powder in 3mL glass ampule
Chemical Formula
C62H98N16O22
CAS number
137525-51-0
Molecular Weight
~1419.5 g/mol
FAQs
What is BPC-157?
BPC-157, or body protection compound-157, is a synthetic pentadecapeptide consisting of 15 amino acids. Its sequence is derived from a segment of human gastric juice protein, and the peptide is stable in gastric acid, which distinguishes it from most peptides that degrade rapidly in acidic environments. BPC-157 research originated in the laboratory of Predrag Sikiric at the University of Zagreb, where it has been studied in over 100 published animal studies since the early 1990s.
What is BPC-157 researched for?
BPC-157 is studied in animal models of tendon, muscle, ligament, and gastrointestinal tissue injury. Research reports accelerated healing of transected rat Achilles tendons, protection against gastric mucosal damage from ethanol and NSAID exposure, and improved healing of surgically created colocutaneous fistulas. Additional research areas include its effects on nitric oxide system modulation, vascular endothelial growth factor expression, and FAK-paxillin pathway activation in wound models.
How does BPC-157 interact with the nitric oxide system?
Research on BPC-157 describes interactions with both nitric oxide synthase and the nitric oxide signaling pathway. Studies in the Journal of Pharmacological Sciences report that BPC-157 counteracts the effects of nitric oxide synthase inhibitors (L-NAME) and nitric oxide donors (L-arginine) in rat models, suggesting the peptide modulates the NO system toward homeostasis rather than acting as a simple agonist or antagonist. This bidirectional modulation is a studied characteristic of BPC-157.
Has BPC-157 been tested in human clinical trials?
BPC-157 has limited human clinical trial data. A Phase 2 clinical trial for inflammatory bowel disease was initiated in 2021 (NCT04711486), but comprehensive published results from large-scale controlled human trials are not yet available. The vast majority of published research on BPC-157 comes from rodent models. The FDA placed BPC-157 in Category 2 on the 503A bulks list in 2023, citing concerns about immunogenicity and impurity risks.
Can I buy BPC-157 for research?
Limitless Peptides sells BPC-157 as a lyophilized powder in a sealed 3mL glass ampule. The product is Janoshik verified for identity, potency, and purity. BPC-157 is sold for research use only and is not approved for human consumption. The product page includes the manufacturer's certificate of analysis and a link to the independent Janoshik verification report.
